Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
New England Journal of Medicine · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (SELECT investigators)
A large randomised, placebo-controlled clinical trial reporting cardiovascular outcomes in the studied population. Cited here as an example of clinical-grade evidence in incretin-pathway research, conducted by third parties and unrelated to any product supplied by Peptiora Labs.
Read study
